Skip to content
healthcare.dev

Trulicity

NDC 0002-2236, Dulaglutide, injection, solution, from Eli Lilly and Company.

Product NDC
0002-2236
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125469
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2236 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DULAGLUTIDE3 mg/.5mL

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Package NDCNDC-11Package
0002-2236-80000022236804 SYRINGE in 1 CARTON (0002-2236-80) / .5 mL in 1 SYRINGE (0002-2236-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/463050bd-2b1c-40f5-b3c3-0a04bb433309
  • NADAC price for package 00002223680

    GET /v1/drugs/nadac/00002223680

Use it

Look up 0002-2236 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2236 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-2236. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.